BIOMAT Database Logo BIOMAT Database Logo

Neostigmine stimulates growth hormone-releasing hormone release into hypophysial portal blood of conscious sheep. 1993

E Magnan, and M Cataldi, and V Guillaume, and L Mazzocchi, and A Dutour, and B Conte-Devolx, and P Giraud, and C Oliver
Laboratoire de Neuroendocrinologie Expérimentale, INSERUM 297, Faculté Médecine Secteur Nord, Marseille, France.

GH secretion is stimulated by the administration of cholinesterase inhibitors (such as pyridostigmine and neostigmine) in several species, including man. On the basis of indirect experiments, it has been postulated that this action is mediated by a decrease in hypothalamic somatostatin release. We have investigated the effect of neostigmine in sheep, since it is possible to collect hypophysial portal blood for GH-releasing hormone (GHRH) and somatostatin determination in this species under a conscious unstressed state. First, after i.v. injection of neostigmine (1 mg), a significant increase in plasma GH levels and an unequivocal potentiation of the GH response to GHRH were observed. Then, we observed that i.v. injection of neostigmine (1 mg) induced an immediate, short-lasting (30 min), and marked increase in GHRH (126.1 +/- 17 vs. 14.5 +/- 2.1 pg/ml; P < 0.01) levels in hypophysial portal blood of rams chronically implanted with perihypophysial cannulae. No change in somatostatin secretion was recorded during the same period. These data suggest that the stimulating effect of cholinergic drugs on GH secretion is mediated by stimulation of GHRH release. A direct effect of neostigmine at the level of pituitary gland is possible and may explain the potentiation of GHRH-induced GH release.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D009388 Neostigmine A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier. Synstigmin,Neostigmine Bromide,Neostigmine Methylsulfate,Polstigmine,Proserine,Prostigmin,Prostigmine,Prozerin,Syntostigmine,Bromide, Neostigmine,Methylsulfate, Neostigmine
D010902 Pituitary Gland A small, unpaired gland situated in the SELLA TURCICA. It is connected to the HYPOTHALAMUS by a short stalk which is called the INFUNDIBULUM. Hypophysis,Hypothalamus, Infundibular,Infundibular Stalk,Infundibular Stem,Infundibulum (Hypophysis),Infundibulum, Hypophyseal,Pituitary Stalk,Hypophyseal Infundibulum,Hypophyseal Stalk,Hypophysis Cerebri,Infundibulum,Cerebri, Hypophysis,Cerebrus, Hypophysis,Gland, Pituitary,Glands, Pituitary,Hypophyseal Stalks,Hypophyses,Hypophysis Cerebrus,Infundibular Hypothalamus,Infundibular Stalks,Infundibulums,Pituitary Glands,Pituitary Stalks,Stalk, Hypophyseal,Stalk, Infundibular,Stalks, Hypophyseal,Stalks, Infundibular
D012039 Regional Blood Flow The flow of BLOOD through or around an organ or region of the body. Blood Flow, Regional,Blood Flows, Regional,Flow, Regional Blood,Flows, Regional Blood,Regional Blood Flows
D003243 Consciousness Sense of awareness of self and of the environment. Consciousnesses
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012756 Sheep Any of the ruminant mammals with curved horns in the genus Ovis, family Bovidae. They possess lachrymal grooves and interdigital glands, which are absent in GOATS. Ovis,Sheep, Dall,Dall Sheep,Ovis dalli
D013004 Somatostatin A 14-amino acid peptide named for its ability to inhibit pituitary GROWTH HORMONE release, also called somatotropin release-inhibiting factor. It is expressed in the central and peripheral nervous systems, the gut, and other organs. SRIF can also inhibit the release of THYROID-STIMULATING HORMONE; PROLACTIN; INSULIN; and GLUCAGON besides acting as a neurotransmitter and neuromodulator. In a number of species including humans, there is an additional form of somatostatin, SRIF-28 with a 14-amino acid extension at the N-terminal. Cyclic Somatostatin,Somatostatin-14,Somatotropin Release-Inhibiting Hormone,SRIH-14,Somatofalk,Somatostatin, Cyclic,Somatotropin Release-Inhibiting Factor,Stilamin,Somatostatin 14,Somatotropin Release Inhibiting Factor,Somatotropin Release Inhibiting Hormone
D013006 Growth Hormone A polypeptide that is secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Growth hormone, also known as somatotropin, stimulates mitosis, cell differentiation and cell growth. Species-specific growth hormones have been synthesized. Growth Hormone, Recombinant,Pituitary Growth Hormone,Recombinant Growth Hormone,Somatotropin,Somatotropin, Recombinant,Growth Hormone, Pituitary,Growth Hormones Pituitary, Recombinant,Pituitary Growth Hormones, Recombinant,Recombinant Growth Hormones,Recombinant Pituitary Growth Hormones,Recombinant Somatotropins,Somatotropins, Recombinant,Growth Hormones, Recombinant,Recombinant Somatotropin

Related Publications

E Magnan, and M Cataldi, and V Guillaume, and L Mazzocchi, and A Dutour, and B Conte-Devolx, and P Giraud, and C Oliver
Intraventricularly injected growth hormone stimulates somatostatin release into rat hypophysial portal blood.
December 1981, Endocrinology,
E Magnan, and M Cataldi, and V Guillaume, and L Mazzocchi, and A Dutour, and B Conte-Devolx, and P Giraud, and C Oliver
Growth hormone-releasing hormone and somatostatin concentrations in the hypophysial portal blood of conscious sheep during the infusion of growth hormone-releasing peptide-6.
May 1996, Domestic animal endocrinology,
E Magnan, and M Cataldi, and V Guillaume, and L Mazzocchi, and A Dutour, and B Conte-Devolx, and P Giraud, and C Oliver
Release of prolactin is independent of the secretion of thyrotrophin-releasing hormone into hypophysial portal blood of sheep.
April 1988, The Journal of endocrinology,
E Magnan, and M Cataldi, and V Guillaume, and L Mazzocchi, and A Dutour, and B Conte-Devolx, and P Giraud, and C Oliver
Thyrotropin and growth hormone releasing activity in hypophysial portal blood.
October 1970, Endocrinology,
E Magnan, and M Cataldi, and V Guillaume, and L Mazzocchi, and A Dutour, and B Conte-Devolx, and P Giraud, and C Oliver
Insulin-induced hypoglycemia stimulates corticotropin-releasing factor and arginine vasopressin secretion into hypophysial portal blood of conscious, unrestrained rams.
June 1990, The Journal of clinical investigation,
E Magnan, and M Cataldi, and V Guillaume, and L Mazzocchi, and A Dutour, and B Conte-Devolx, and P Giraud, and C Oliver
Prostaglandin D2 stimulates vasoactive intestinal polypeptide release into rat hypophysial portal blood.
January 1984, Peptides,
E Magnan, and M Cataldi, and V Guillaume, and L Mazzocchi, and A Dutour, and B Conte-Devolx, and P Giraud, and C Oliver
Human pancreatic growth hormone-releasing factor stimulates release of growth hormone in conscious unrestrained male rabbits.
December 1983, Endocrinology,
E Magnan, and M Cataldi, and V Guillaume, and L Mazzocchi, and A Dutour, and B Conte-Devolx, and P Giraud, and C Oliver
Nature of luteinizing hormone releasing factor in hypophysial portal blood.
July 1967, Nature,
E Magnan, and M Cataldi, and V Guillaume, and L Mazzocchi, and A Dutour, and B Conte-Devolx, and P Giraud, and C Oliver
Effects of intracerebroventricular administration of growth hormone-releasing factor and corticotropin-releasing factor on somatostatin secretion into rat hypophysial portal blood.
January 1990, Neuroendocrinology,
E Magnan, and M Cataldi, and V Guillaume, and L Mazzocchi, and A Dutour, and B Conte-Devolx, and P Giraud, and C Oliver
Estrogen inhibition of dopamine release into hypophysial portal blood.
February 1979, Endocrinology,
Copied contents to your clipboard!